The Leukemia & Lymphoma Society (LLS) is planning on re-initiating our special grant program, Screen to Lead Program (SLP) for FY17. A call for applications will be announced in July 2016 for a planned program launch in July 2017. SLP was previously run for two years in FY13 and FY14. This Request for Applications (RFA) from qualified academic laboratories is for drug discovery support specifically directed towards medicinal chemistry and/or drug target screening in hematological malignancies. LLS recognizes a significant need for investigators to receive resources for high-throughput screening and/or optimization of small molecules into drug-like compounds. These grants will be peer reviewed by a special committee and are anticipated to be for two years. Questions about the program can be directed to James.Kasper@lls.org .
The LLS is not currently accepting applications for the Screen to Lead program.
How to Apply/Deadlines
LLS uses its own Research Portal powered by FLUXX for Letter of Intent (LOI) and full application submission.
|Call for Proposals||July 1, 2016||CLOSED|
|August 29, 2016||3:00 PM ET|
|Scientific Peer Review Committee||October 2016|
|Notification of Awards||November 2016|
|Anticipated Funding Start Date||July 1, 2017|